Prediction of Treatment Response Improved by Genotyping Hepatitis C Patients

by Kathy Jones on  September 15, 2011 at 7:57 PM General Health News
RSS Email Print This Page Comment bookmark
Font : A-A+

David Booth of the University of Sydney, Australia and colleagues have reported that genotyping hepatitis C patients for the IL28B, HLA-C and KIR genes substantially improves doctors' ability to predict whether or not patients will respond to antiviral treatment. The report appears in this week's PLoS Medicine.
 Prediction of Treatment Response Improved by Genotyping Hepatitis C Patients
Prediction of Treatment Response Improved by Genotyping Hepatitis C Patients

The results of the study suggest that an interaction between IL28B, HLA-C and KIRs provides a mechanism for hepatitis C viral control and highlight new insights into how the drug combination of pegylated interferon alpha and ribavirin clears hepatitis C virus infections, findings that may lead to improved therapies in the future. The findings have yet to be confirmed in patients of non-European descent.



Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Hepatitis A Hepatitis B Vasculitis Silent Killer Diseases Liver Aplastic Anemia Hepatitis C Hepatitis Needlestick Injuries New Treatments for Hepatitis C 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive